| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/07/2006 | CA2609777A1 Methods and compositions to enhance plant breeding |
| 12/07/2006 | CA2609543A1 Mutant il-10 |
| 12/07/2006 | CA2609262A1 Anti-cd14 antibody fusion protein |
| 12/07/2006 | CA2609234A1 Anti-il2 antibodies |
| 12/07/2006 | CA2609226A1 Coagulation factor x polypeptides with modified activation properties |
| 12/07/2006 | CA2573987A1 Plant polynucleotides for improved yield and quality |
| 12/07/2006 | CA2550115A1 Strong pcr primers and primer cocktails |
| 12/06/2006 | EP1729136A1 Method of agitating solution |
| 12/06/2006 | EP1729105A1 Multi-format sample processing devices, methods and systems |
| 12/06/2006 | EP1728874A1 Method for the preparation of an in vitro surrogate for identifying expressed genes in a test sample |
| 12/06/2006 | EP1728871A2 Particle mediated transformation of soyabean with glyphosate selection |
| 12/06/2006 | EP1728870A2 Transcription factor stress-related proteins and methods of use in plants |
| 12/06/2006 | EP1728869A2 Gene expression construct of hap1 adapted for plant cells |
| 12/06/2006 | EP1728868A2 Herbicide resistant plants |
| 12/06/2006 | EP1728867A2 Genes coding for flavone synthases |
| 12/06/2006 | EP1728866A2 Luciferase expression cassettes and methods of use |
| 12/06/2006 | EP1728865A1 Treatment of cervical cancer |
| 12/06/2006 | EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
| 12/06/2006 | EP1728863A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 12/06/2006 | EP1728862A1 Methods and compositions for RNA interference |
| 12/06/2006 | EP1728860A1 Method for producing polymers |
| 12/06/2006 | EP1728859A1 Sequence capable of accelerating gene expression at moderately low temperature |
| 12/06/2006 | EP1728857A2 Liver tissue source |
| 12/06/2006 | EP1728802A2 ErbB3 antibodies |
| 12/06/2006 | EP1728801A1 Subtype of humanized antibody against interleukin-6 receptor |
| 12/06/2006 | EP1728800A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 12/06/2006 | EP1728798A1 Coagulation factor X polypeptides with modified activation properties |
| 12/06/2006 | EP1728518A1 Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 12/06/2006 | EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 12/06/2006 | EP1728514A1 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 12/06/2006 | EP1728441A2 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 12/06/2006 | EP1728423A2 Transgenic animal model of neurodegenerative disorders |
| 12/06/2006 | EP1728418A1 Method of transforming monocotyledonous seed |
| 12/06/2006 | EP1728074A1 Method for extracting intracellular complexes or compounds from a sample containing cells in a liquid suspension |
| 12/06/2006 | EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 12/06/2006 | EP1727910A1 Method of detecting nucleic acid using amplification on an array |
| 12/06/2006 | EP1727907A1 Post harvest control of genetically modified crop growth employing d-amino acid compounds |
| 12/06/2006 | EP1727906A1 Improved constructs for marker excision based on dual-function selection marker |
| 12/06/2006 | EP1727905A2 Barley for production of flavor-stable beverage |
| 12/06/2006 | EP1727904A1 Peptide-based method for monitoring gene expression in a host cell |
| 12/06/2006 | EP1727903A1 Modified xylanases exhibiting improved expression |
| 12/06/2006 | EP1727902A1 Expression of nitrille hydratases in a two-vector expression system |
| 12/06/2006 | EP1727901A2 Materials and methods for treatment of cancer |
| 12/06/2006 | EP1727900A1 Method for selectively separating and purifying rna and method for separating and purifying nucleic acid |
| 12/06/2006 | EP1727899A2 Method |
| 12/06/2006 | EP1727898A2 Amylases, nucleic acids encoding them and methods for making and using them |
| 12/06/2006 | EP1727895A2 Novel alcohol dehydrogenases |
| 12/06/2006 | EP1727889A1 Ready-to-use electroporation cuvette including frozen electrocompetent cells |
| 12/06/2006 | EP1727833A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof |
| 12/06/2006 | EP1727832A2 Antigen of the pm-2 antibody and use thereof |
| 12/06/2006 | EP1727831A1 Genes and polypeptides relating to prostate cancers |
| 12/06/2006 | EP1727830A1 Mussel bioadhesive |
| 12/06/2006 | EP1727826A2 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 12/06/2006 | EP1727567A2 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 12/06/2006 | EP1727560A2 Gastrointestinal proliferative factor and uses thereof |
| 12/06/2006 | EP1727423A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 12/06/2006 | EP1670307A4 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 12/06/2006 | EP1629106A4 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 12/06/2006 | EP1608755A4 Tak1-mediated inhibition of osteogenesis |
| 12/06/2006 | EP1576152B1 Thermostable alpha-amylases |
| 12/06/2006 | EP1495136B1 Nucleic acid quantification |
| 12/06/2006 | EP1490493B1 Enhancer sequence of the 5-aminolevulinic acid synthase gene |
| 12/06/2006 | EP1476547B1 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 12/06/2006 | EP1456222A4 Non-human primate fc receptors and methods of use |
| 12/06/2006 | EP1430304B1 Method for diagnosing chronic inflammatory bowel diseases |
| 12/06/2006 | EP1422991A4 Method for increasing stress tolerance in plants |
| 12/06/2006 | EP1404878A4 Internal calibration standards for electrophoretic analyses |
| 12/06/2006 | EP1390519B1 Microorganisms and processes for enhanced production of pantothenate |
| 12/06/2006 | EP1370870B1 Diagnostic screens for alzheimer's disease |
| 12/06/2006 | EP1353688B1 Method and compositions for immunization with the pseudomonas v antigen |
| 12/06/2006 | EP1290158B1 Processing of plasmid-containing fluids |
| 12/06/2006 | EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 12/06/2006 | EP1198598B1 Prophage dna sequences and their use in determining instability in lactobacilli cultures |
| 12/06/2006 | EP1166797B1 Method for quality control of an attenuated varicella live vaccine |
| 12/06/2006 | EP1144661B1 Method of genetic modification of a wild type viral sequence |
| 12/06/2006 | EP1117685B1 Treatment of inflammatory disease |
| 12/06/2006 | EP1114830B1 Cerebral organic anion transporter and its gene |
| 12/06/2006 | EP1078001B1 Il-6 antagonist peptides |
| 12/06/2006 | EP1054971B1 Group b streptococcus antigens |
| 12/06/2006 | EP1025226B1 Dna encoding a human proton-gated ion channel and uses thereof |
| 12/06/2006 | EP1007686B1 Tuberculosis vaccine |
| 12/06/2006 | EP1003908B1 Nucleic acid archiving |
| 12/06/2006 | EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 12/06/2006 | EP0912749B1 Suppression of specific classes of soybean seed protein genes |
| 12/06/2006 | EP0910406B1 Recombinant canine herpesviruses |
| 12/06/2006 | EP0843729B1 Haloperoxidases from curvularia verruculosa and nucleic acids encoding same |
| 12/06/2006 | EP0837934B1 Human vascular endothelial growth factor 2 |
| 12/06/2006 | EP0812333B1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 12/06/2006 | EP0740701B1 Mammalian monocyte chemoattractant protein receptors |
| 12/06/2006 | EP0717107B1 Transformant line of candida utilis yeast and expression of heterogene therewith |
| 12/06/2006 | EP0688362B1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 12/06/2006 | CN1875112A Method for producing zeaxanthin |
| 12/06/2006 | CN1875111A Production of high mannose proteins in plant culture |
| 12/06/2006 | CN1875108A Method for producing succinic acid |
| 12/06/2006 | CN1875107A Vectors |
| 12/06/2006 | CN1875106A Recombinant microorganism |
| 12/06/2006 | CN1875105A Wheat with altered branching enzyme activity and starch and starch containing products derived therefrom |
| 12/06/2006 | CN1875104A Anti-angiogenic peptides from the N-terminus of endostatin |
| 12/06/2006 | CN1875103A Method of searching for functional nucleotide molecule |
| 12/06/2006 | CN1875102A Novel plasmids and utilization thereof |